phenylbutazone has been researched along with Cardiovascular Diseases in 5 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, A | 1 |
| Pagidipati, NJ | 1 |
| Califf, RM | 1 |
| McGuire, DK | 1 |
| Green, JB | 1 |
| Demets, D | 1 |
| George, JT | 1 |
| Gerstein, HC | 1 |
| Hobbs, T | 1 |
| Holman, RR | 1 |
| Lawson, FC | 1 |
| Leiter, LA | 1 |
| Pfeffer, MA | 1 |
| Reusch, J | 1 |
| Riesmeyer, JS | 1 |
| Roe, MT | 1 |
| Rosenberg, Y | 1 |
| Temple, R | 1 |
| Wiviott, S | 1 |
| McMurray, J | 1 |
| Granger, C | 1 |
| Jobin, F | 1 |
| Visintini, E | 1 |
| Britov, AN | 1 |
| Siderskiĭ, AL | 1 |
| Suchan, P | 1 |
2 reviews available for phenylbutazone and Cardiovascular Diseases
| Article | Year |
|---|---|
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arterioscl | 1976 |
[Gastro-duodenal disorders in patients with cardiovascular diseases].
Topics: Adrenal Cortex Hormones; Animals; Arteriosclerosis; Cardiovascular Diseases; Cats; Cerebrovascular D | 1971 |
3 other studies available for phenylbutazone and Cardiovascular Diseases
| Article | Year |
|---|---|
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; | 2020 |
[Iatrogenic damage in therapy with phenylbutazone].
Topics: Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Drug Eruptions; Endocrine System Di | 1971 |
[Polyclinical experience with a pyrazolone-pyrazolidine derivative].
Topics: Analgesics; Cardiovascular Diseases; Drug Synergism; Endocarditis; Humans; Joint Diseases; Myocardit | 1967 |